AMPO Biotechnology

Ampo Biotechnology is a precision medicine company based in Taiwan that specializes in liquid biopsy and circulating tumor cell (CTC) technologies. The company's core platform, i-Quate, utilizes immunomagnetic beads to isolate and enrich CTCs from blood samples with high sensitivity and specificity. This technology enables non-invasive monitoring of cancer progression, treatment response, and the detection of specific biomarkers such as PD-L1 and AR-V7. Ampo Biotechnology provides both automated systems for laboratory use and clinical testing services to support personalized oncology care. Their solutions are designed to assist clinicians in making informed decisions for various solid tumors, including breast, lung, and colorectal cancers.